当前位置:首页 - 行情中心 - 常山药业(300255) - 财务分析

常山药业

(300255)

  

流通市值:193.26亿  总市值:193.92亿
流通股本:9.16亿   总股本:9.19亿

常山药业(300255)财务分析

净利润 + 每股收益
------
  • 净利润(亿元)
  • 每股收益(元)

    截至第三季度实现净利润-0.28亿元,每股收益0.01元。

股东权益 + 未分配利润
------
  • 股东权益(亿元)
  • 未分配利润(亿元)

    截至第三季度最新股东权益177188.81万元,未分配利润29164.35万元。

总资产 + 负债
------
  • 总资产(亿元)
  • 负债(亿元)

    截至第三季度最新总资产468623.19万元,负债291434.39万元。

利润表
报告期2024-09-302024-06-302024-03-312023-12-31
营业总收入784,021,902.08567,776,898.46294,318,791.371,410,439,649.66
营业总成本874,012,625.11639,945,832.06355,149,467.252,005,215,648.54
营业利润-57,480,721.53-44,205,564.13-59,521,417.38-1,226,324,879.49
利润总额-25,504,900.85-45,552,062.12-59,510,763.59-1,231,694,786.11
净利润-27,806,023.52-46,905,821.3-62,005,917.65-1,248,154,115.23
其他综合收益2,004.7739,961.99-43,398.03-1,582,310.32
综合收益总额-27,804,018.75-46,865,859.31-62,049,315.68-1,249,736,425.55
资产负债表
报告期2024-09-302024-06-302024-03-312023-12-31
流动资产合计2,240,476,218.622,370,666,935.422,308,260,145.742,275,859,098.66
非流动资产合计2,445,755,711.692,404,443,607.972,361,905,080.122,320,594,888.49
资产总计4,686,231,930.314,775,110,543.394,670,165,225.864,596,453,987.15
流动负债合计1,974,421,339.952,333,413,246.181,938,685,432.61,920,921,469.78
非流动负债合计939,922,534.26688,871,081.67993,750,238.03875,840,442.52
负债合计2,914,343,874.213,022,284,327.852,932,435,670.632,796,761,912.3
归属于母公司股东权益合计1,818,949,472.071,764,794,675.571,750,035,675.661,811,657,375.57
股东权益合计1,771,888,056.11,752,826,215.541,737,729,555.231,799,692,074.85
负债和股东权益合计4,686,231,930.314,775,110,543.394,670,165,225.864,596,453,987.15
现金流量表
报告期2024-09-302024-06-302024-03-312023-12-31
经营活动现金流入小计862,960,667.08686,876,721.39304,049,594.671,600,484,147.57
经营活动现金流出小计712,614,035.91485,585,848.55190,106,717.831,566,758,168.26
经营活动产生的现金流量净额150,346,631.17201,290,872.84113,942,876.8433,725,979.31
投资活动现金流入小计625,0002,515,000425,00029,837,384.76
投资活动现金流出小计118,906,224.7694,110,645.9448,605,901.53268,684,026.87
投资活动产生的现金流量净额-118,281,224.76-91,595,645.94-48,180,901.53-238,846,642.11
筹资活动现金流入小计1,705,760,860929,200,000507,190,717.71,371,455,438.58
筹资活动现金流出小计1,654,738,866.42931,244,248.19481,662,935.421,666,400,199.28
筹资活动产生的现金流量净额51,021,993.58-2,044,248.1925,527,782.28-294,944,760.7
汇率变动对现金及现金等价物的影响244,412.69231,686.05-208,032.643,033,527.56
现金及现金等价物净增加额83,331,812.68107,882,664.7691,081,724.95-497,031,895.94
期末现金及现金等价物余额314,190,232.52338,741,084.6321,940,144.79230,858,419.84
TOP↑